✦ LIBER ✦

PP-094 Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

✍ Scribed by L.-J. Sun; J.-W. Yu; P. Kang

Book ID: 118617496
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 44 KB
Volume: 14
Category: Article
ISSN: 1201-9712
DOI: 10.1016/s1201-9712(10)60162-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influential factors of prognosis in lami

Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

✍ Li-Jie Sun; Jian-Wu Yu; Yong-Hua Zhao; Peng Kang; Shu-Chen Li 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

PP-081 Analysis of influential factors o

PP-081 Analysis of influential factors of prognosis of patients with acute-on-chronic hepatitis B liver failure after lamivudine treatment

✍ Li-jie Sun; Jian-wu Yu; Yong-hua Zhao; Shu-chen Li; Shu-chen Li 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

PP-048 Prediction value of MELD scoring

PP-048 Prediction value of MELD scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment

✍ J.W. Yu; L.J. Sun; Y.H. Zhao; S.C. Li 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Prediction value of model for end-stage

Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment

✍ Jian-Wu Yu; Li-Jie Sun; Yong-Hua Zhao; Shu-Chen Li 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Short-term entecavir versus lamivudine t

Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure

✍ Lai, Jing; Yan, Ying; Mai, Li; Zheng, Yu-Bao; Gan, Wei-Qiang; Ke, Wei-Min 📂 Article 📅 2013 🏛 Zhejiang University School of Medicine, China 🌐 English ⚖ 175 KB

750 EFFICACY AND SAFETY OF ENTECAVIR VER

750 EFFICACY AND SAFETY OF ENTECAVIR VERSUS LAMIVUDINE IN TREATMENT-NAÏVE CHRONIC HEPATITIS B PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE: 48 WEEKS RESULTS

✍ Zhang, Y.; Hu, X.-Y.; Wang, Y.-Y.; Chen, G.; Chen, J.; Zhang, C.-T.; Zhong, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 202 KB